Law360, New York (March 09, 2007, 12:00 AM ET) -- Foreign purchasers of monosodium glutamate and nucleotides in transactions occurring outside the United States had their hopes dashed last month when the Eighth Circuit Court of Appeals ruled that it lacked subject-matter jurisdiction to adjudicate allegations of a global price-fixing and market allocation conspiracy. In re Monosodium Glutamate Antitrust Litig., 2007 WL 414358 (8th Cir. 2007) (MSG).
The Eighth Circuit joined the D.C. Circuit as the second federal appellate court in the wake of the Supreme Court’s 2004 Empagran decision to dismiss such Sherman Act claims...
Global Cartels Under The FTAIA
To view the full article, take a free trial now.
